重视肝硬化患者心肺功能状况的评估

doi:10.3969/j.issn.1672-5069.2015.05.001

摘要/Abstract

Key words: Liver cirrhosis, Cirrhotic cardiomyopathy, Hepatopulmonary syndrome, Portopulmonary hypertension

刘玉兰. 重视肝硬化患者心肺功能状况的评估[J]. 实用肝脏病杂志, 2015, 18(5): 449-452.

Liu Yulan. Cardiac and pulmonary functions in patients with liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 449-452.

[1] Ma ZH，Lee SS. Cirrhotic cardiopulmonary:getting to the heart of the matter. Hepatology，1996，14:606-608.
[2] Moller S，Krag A，Bendtsen F. Kidney injury in cirrhosis:pathophysiological and therapeutic aspects of hepatorenal syndromes. Liver Int，2014，34:1153-1163.
[3] Grace JA，Klein S，Herath CB，et al. Activation of the MAS receptor by angiotensin-（1-7） in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis. Gastroenterology，2013，145:874-884.
[4] Wiese S，Hove JD，Bendtsen F，et al. Cirrhotic cardiomyopathy:pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol，2014，11（3）:177-186.
[5] Blendis L，Wong F. Is there a cirrhotic cardiomyopathy. Am J Gastroenterol，2000，95:3026-3028.
[6] Fede G， Privitera G，Tomaselli T，et al. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol，2015，28:31-40.
[7] Han S，Meller S，Bendtsen F，et al. Diurnal variation and dispersion in QT interval in cirrhosis:relation to haemodynamic changes. J Hepatol，2007，47（3）:373-380.
[8] Zambruni A，Trevisani F，Caraceni P，et al. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol，2006，44:994-1002.
[9] Kennedy TC，Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest，1977，72:305-309.
[10] Grace JA，Angus PW. Hepatopulmonary syndrome:update on recent advances in pathophysiology，investigation，and treatment. J Gastroenterol Hepatol，2013，28:213-219.
[11] Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension:distinctions and dilemmas. Hepatology，1997，25:1282-1284.
[12] Khan AN，Al-Jahdali H，Abdullah K，et al. Pulmonary vascular complications of chronic liver disease:Pathophysiology，imaging，and treatment. Ann Thorac Med，2011，6:57-65.
[13] Hoeper MM，Krowka MJ，Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet，2004，363:1461-1468.
[14] 王爱鱼，侯培珍，高军. 肝硬化所致心脏损害-附96例尸解分析. 中华消化杂志，1998，18:184.
[15] Ruiz-del-Arbol L，Monescillo A，Arocena C，et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology，2005，42:439-447.
[16] Ruiz-del-Arbol L，Urman J，Fernandez J，et al. Systemic，renal， and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology，2003，38:1210-1218.
[17] Ronco C，Haapio M，House AA，et al. Cardiorenal syndrome. J Am Coll Cardiol，2008，52:1527-1539.
[18] Azoulay D，Castaing D，Dennison A，et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient:preliminary report of a prospective study. Hepatology，1994，19:129-132.
[19] 王芳，刘玉兰，王岩，等. 肝硬化患者心功能的临床研究. 胃肠病学和肝病学杂志，2003，10（12）464-466.
[20] Chen B，Wang W，Tam MD，et al. Transjugular intrahepatic portosystemic shunt in liver transplant recipients:indications，feasibility，and outcomes. Hepatol Int，2015 9（3）:391-398.
[21] Rabie RN，Cazzaniga M，Salerno F，et al. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol， 2009，104:2458-2466.
[22] Fouad TR，bdel-Razek WM，Burak KW，et al. Prediction of cardiac complications after liver transplantation. Transplantation，2009，87:763-770.
[23] Fede G，Privitera G，Tomaselli T，et al. Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol，2015，28，31-40.
[24] Schenk P，Schoniger-Hekele M，Fuhrmann V，et al Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology，2003，125:1042-1052.
[25] Schenk P，Schoniger-Hekele M，Fuhrmann V，et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology，2003，125:1042-1052.
[26] Palma DT，Philips GM，Arguedas MR，et al. Oxygen desaturation during sleep in hepatopulmonary syndrome. Hepatology，2008，47:1257-1263.
[27] Machicao VI，Balakrishnan M，Fallon MB. Pulmonary complications in chronic liver disease. Hepatology，2014，59:1627-1637.
[28] Swanson KL，Wiesner RH，Krowka MJ. Natural history of hepatopulmonary syndrome:impact of liver transplantation. Hepatology，2005，41:1122-1129.
[29] De BK，Dutta D，Pal SK，et al. The role of garlic in hepatopulmonary syndrome:a randomized controlled trial. Can J Gastroenterol，2010，24:183-188.
[30] Martinez-Palli G，Drake BB，Garcia-Pagan JC，et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol，2005，11:6858-6862.
[31] Gupta S，Castel H，Rao RV，et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant，2010，10:354-363.
[32] Hadengue A，Benhayoun MK，Lebrec D，et al. Pulmonary hypertension complication portal hypertension:prevalence and relation to splanchnic hemodynamic. Gastroenterology，1991，100:520-528.
[33] Torregrosa M，Genesca J，Gonzalez A，et al. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplant candidates. Transplantation，2001，71:572-574.
[34] Krowka MJ，Pleak DJ，Findlay JY，et al.Pulmonary hemodynamics and perioperative cardiopulmonaryrelated mortality in patients with portopulmonary hypertension undergoing liver transplantation.Liver Transplant，2000，6:443-450.

重视肝硬化患者心肺功能状况的评估

Cardiac and pulmonary functions in patients with liver cirrhosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[2]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[3]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[4]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[5]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[6]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[7]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[8]	王月圆, 王燕, 张丹丹. 奥曲肽辅助特利加压素治疗失代偿期肝硬化并发肝肾综合征患者疗效分析*[J]. 实用肝脏病杂志, 2019, 22(5): 684-687.
[9]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.
[10]	丹珠永吉, 刘芝兰, 禄艳艳, 蒋汉梅. 内镜下序贯套扎和硬化剂治疗肝硬化并发食管胃底静脉曲张破裂出血患者疗效及对血流动力学的影响对比研究*[J]. 实用肝脏病杂志, 2019, 22(5): 692-695.
[11]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[12]	赵芳芳, 翟永贞, 冯国和. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者疗效及安全性分析[J]. 实用肝脏病杂志, 2019, 22(5): 700-703.
[13]	陈山, 庄华帅, 邢诒喜, 吴直佳. 美罗培南治疗肝硬化并发上消化道出血患者对感染预防和再出血的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 704-707.
[14]	徐祺林, 郝少欢, 冉博. 肝硬化脾切除术后门静脉系统血栓形成的危险因素分析*[J]. 实用肝脏病杂志, 2019, 22(5): 708-711.
[15]	金良红, 李兴杰, 关红博, 麻少辉. 双能量CT碘定量结合动态对比增强MRI评估肝硬化患者肝脏血流动力学和肝功能临床价值研究*[J]. 实用肝脏病杂志, 2019, 22(5): 712-715.